Urine orotic acid-orotidine levels in azaribine-treated patients with psoriasis.
D000284:Administration, Oral; D001372:Aza Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000139:chemically induced; D003404:Creatinine / Q000652:urine; D006801:Humans; D009963:Orotic Acid / Q000652:urine*; D011565:Psoriasis / Q000188:drug therapy* / Q000652:urine; D012263:Ribonucleosides / Q000652:urine*; D013053:Spectrophotometry; D014529:Uridine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001372:Aza Compounds; D012263:Ribonucleosides; D009963:Orotic Acid; D003404:Creatinine; D014529:Uridine